Observed impairment in reciprocal social interaction is a diagnostic hallmark of autism
spectrum disorders. There is no effective medical treatment for these problems …

Autism is a neurodevelopmental disorder characterized by dysfunction in three core
symptom domains: speech and communication deficits, repetitive or compulsive behaviors …

Autism spectrum disorder is a prevalent neurodevelopmental disorder with no established
pharmacological treatment for its core symptoms. Although previous literature has shown …

Autism is a developmental disorder characterized by three core symptom domains: speech
and communication abnormalities, social functioning impairments and repetitive behaviours …

The prevalence of autism spectrum disorder (ASD) is as high as 1 in 100 individuals and is a
heavy burden to society. Thus, identifying causes and treatments is imperative. Here, we …

Oxytocin is a potential therapeutic for the core symptoms of autism spectrum disorder (ASD),
which is currently untreatable with pharmacotherapy. Previous clinical trials of a single dose …

Autism spectrum disorder (ASD) is a neurodevelopmental disorder whose core symptoms
include deficits in social interaction and communication besides restricted and repetitive …

A recent clinical trial found no effect of chronic intranasal oxytocin on social behaviour in
children with autism spectrum disorders. The result is not surprising, as oxytocin facilitates …

Aim: Oxytocin presents an exciting potential to target the core symptoms of autism spectrum
disorder (ASD) pharmacologically in an easily administered, cost-effective form with possibly …

Social dysfunction is a core symptom of many psychiatric disorders and current medications
have little or no remedial effects on this. Following on from extensive studies on animal …